"As a regional destination for cancer care, Mary Bird Perkins Cancer Center in Baton Rouge offers the most advance technology and services provided by a dedicated team of nationally-recognized oncology experts. The Cancer Center provides best-practice, comprehensive care at every stage of the cancer journey, including disease site-specific multidisciplinary care teams, a robust clinical research program, extensive supportive care services and is the only facility in the Gulf South with the revolutionary Leksell Gamma Knife®Icon™. As a nonprofit organization, donor generosity is essential to sustaining the mission of improving survivorship and lessening the burden of cancer for so many throughout SE Louisiana and beyond."

During the past decade, Mary Bird Perkins Our Lady of the Lake Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mary Bird Perkins Our Lady of the Lake Cancer Center" #1 collaborator was "Bayer" with 2 trials as a collaborator, "Berman Center for Outcomes and Clinical Research" with 2 trials as a collaborator, "Monash University" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator and "National Health and Medical Research Council, Australia" with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Mary Bird Perkins Our Lady of the Lake Cancer Center" are "Cancer" (2 trials), "Bleeding" (1 trials), "Dementia" (1 trials), "Depression" (1 trials) and "Functional Disability" (1 trials). Many other conditions were trialed in "Mary Bird Perkins Our Lady of the Lake Cancer Center" in a lesser frequency.

Most popular intervention types in "Mary Bird Perkins Our Lady of the Lake Cancer Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "100 mg enteric-coated aspirin" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mary Bird Perkins Our Lady of the Lake Cancer Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mary Bird Perkins Our Lady of the Lake Cancer Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Mary Bird Perkins Our Lady of the Lake Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mary Bird Perkins Our Lady of the Lake Cancer Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".